NCT02981368 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 268
- group Id
- BG001
- value
- 117
- group Id
- BG002
- value
- 385
- units
- Participants
- groups
- description
- Patients with high risk prostate cancer planned for radical prostatectomy with pelvic lymph node dissection were enrolled to receive a single dose of 9 mCi (333 MBq) IV injection of 18F-DCFPyL, followed by PET/CT imaging acquired 1-2 hours post-PyL injection.
- id
- BG000
- title
- High Risk Prostate Cancer (Cohort A)
- description
- Patients with presumptive radiologic evidence of prostate cancer recurrence or metastasis on conventional imaging and planned for conventional image-guided biopsy were enrolled to receive a single dose of 9 mCi (333 MBq) IV injection of 18F-DCFPyL, followed by PET/CT imaging acquired 1-2 hours post-PyL injection.
- id
- BG001
- title
- Recurrent or Metastatic Prostate Cancer (Cohort B)
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 46
- upper Limit
- 84
- value
- 65
- group Id
- BG001
- lower Limit
- 45
- upper Limit
- 86
- value
- 68
- group Id
- BG002
- lower Limit
- 45
- upper Limit
- 86
- value
- 66
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Female
- measurements
- group Id
- BG000
- value
- 268
- group Id
- BG001
- value
- 117
- group Id
- BG002
- value
- 385
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 233
- group Id
- BG001
- value
- 101
- group Id
- BG002
- value
- 334
- title
- White
- measurements
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 29
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 11
- title
- Asian
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 5
- title
- Other
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 6
- title
- Unknown or Not Reported
- title
- Race
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- population Description
- Safety population; total number of patients who received 18F-DCFPyL injection.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 268
- group Id
- BG001
- value
- 117
- group Id
- BG002
- value
- 385
- units
- Participants
- groups
- description
- Patients with high risk prostate cancer planned for radical prostatectomy with pelvic lymph node dissection were enrolled to receive a single dose of 9 mCi (333 MBq) IV injection of 18F-DCFPyL, followed by PET/CT imaging acquired 1-2 hours post-PyL injection.
- id
- BG000
- title
- High Risk Prostate Cancer (Cohort A)
- description
- Patients with presumptive radiologic evidence of prostate cancer recurrence or metastasis on conventional imaging and planned for conventional image-guided biopsy were enrolled to receive a single dose of 9 mCi (333 MBq) IV injection of 18F-DCFPyL, followed by PET/CT imaging acquired 1-2 hours post-PyL injection.
- id
- BG001
- title
- Recurrent or Metastatic Prostate Cancer (Cohort B)
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 46
- upper Limit
- 84
- value
- 65
- group Id
- BG001
- lower Limit
- 45
- upper Limit
- 86
- value
- 68
- group Id
- BG002
- lower Limit
- 45
- upper Limit
- 86
- value
- 66
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Female
- measurements
- group Id
- BG000
- value
- 268
- group Id
- BG001
- value
- 117
- group Id
- BG002
- value
- 385
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 233
- group Id
- BG001
- value
- 101
- group Id
- BG002
- value
- 334
- title
- White
- measurements
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 29
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 11
- title
- Asian
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 5
- title
- Other
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 6
- title
- Unknown or Not Reported
- title
- Race
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- population Description
- Safety population; total number of patients who received 18F-DCFPyL injection.
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle